Literature DB >> 26315394

The Diagnostic Value of Routine Papanicolaou Smears for Detecting Endometrial Cancers: An Update.

Chiung-Ru Lai1, Chih-Yi Hsu, Jen-Fan Hang, Anna Fen-Yau Li.   

Abstract

OBJECTIVE: The presence of degenerative endometrial debris and abnormal endometrial cells is considered to be the hint for endometrial pathology. The purpose of this study was to evaluate the efficacy of Papanicolaou (Pap) smears in detecting endometrial cancers. STUDY
DESIGN: There were 146 cases of endometrial cancer diagnosed at our institute in 2000-2002 and 271 in 2010-2012. Among them, 57 and 95 relevant reports of Pap smears 6 months prior to the histology diagnosis were retrieved for this study, respectively. In the first time period, new criteria for detecting endometrial lesions had not yet been incorporated into routine screening.
RESULTS: Twenty cases (21%) of adenocarcinoma, 12 (13%) of atypical glandular cells, 4 (4%) of endometrial debris and 59 (62%) negative reports were found among the more recent 95 relevant Pap smears. The overall efficacy of the Pap smear for detecting endometrial malignancy was 38%, higher than 10 years previously (30%).
CONCLUSION: Although the Pap smear was originally designed to screen cervical lesions, more effective detection of endometrial lesions could be achieved by adding new criteria to the routine screening.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2015        PMID: 26315394     DOI: 10.1159/000438975

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  6 in total

1.  Preoperative cervical cytology as a prognostic factor in endometrioid-type endometrial cancer: A single-center experience from Saudi Arabia.

Authors:  Ahmed Abu-Zaid; Mohannad Alsabban; Osama Alomar; Mohammed Abuzaid; Mohammed Z Jamjoom; Hany Salem; Ismail A Al-Badawi
Journal:  Avicenna J Med       Date:  2020-07-03

2.  Diagnostic Role of Papanicolaou Smear, Hemoglobin, Blood Group, and Other Clinical Symptoms in Detecting Endometrial Carcinoma: A Clinicopathological Study of 175 Iranian Women with Endometrial Carcinoma.

Authors:  Maryam Sadat Hosseini; Shima Mohammadian; Farah Farzaneh; Maliheh Arab; Tahereh Ashrafganjoei
Journal:  Gynecol Minim Invasive Ther       Date:  2020-08-01

Review 3.  The value of cell-free DNA for molecular pathology.

Authors:  Caitlin M Stewart; Prachi D Kothari; Florent Mouliere; Richard Mair; Saira Somnay; Ryma Benayed; Ahmet Zehir; Britta Weigelt; Sarah-Jane Dawson; Maria E Arcila; Michael F Berger; Dana Wy Tsui
Journal:  J Pathol       Date:  2018-03-12       Impact factor: 7.996

4.  The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.

Authors:  Cheng Chang Chang; Hui Chen Wang; Yu Ping Liao; Yu Chih Chen; Yu Chun Weng; Mu Hsien Yu; Hung Cheng Lai
Journal:  J Gynecol Oncol       Date:  2018-01       Impact factor: 4.401

5.  Pap Smears in Endometrial Adenocarcinoma: Does It Have a Role?

Authors:  Asma Nadaf; Hephzibah Rani; Parinitha S S; Ravikala Rao; Dinesh Shastri
Journal:  Asian Pac J Cancer Prev       Date:  2017-04-01

6.  Association of Abnormal Pap Smear with Occult Cervical Stromal Invasion in Patients with Endometrial Cancer.

Authors:  Kewalin Khumthong; Apiwat Aue-Aungkul; Pilaiwan Kleebkaow; Bandit Chumworathayi; Amornrat Temtanakitpaisan; Wilasinee Nhokaew
Journal:  Asian Pac J Cancer Prev       Date:  2019-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.